Harvard Bioscience to Present at Sidoti Micro Cap Virtual Conference May 10th, 2023
May 02, 2023 17:01 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., May 02, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one...
Harvard Bioscience Announces First Quarter 2023 Financial Results
April 25, 2023 08:01 ET
|
Harvard Bioscience, Inc.
Q1 Revenues of $30 million up 4% over prior year periodQ1 GAAP Operating Income of $1.7 million up from a loss of $6.7 million prior yearQ1 Adjusted Operating Income of $4.4 million up from $2.4...
Harvard Bioscience Announces Initial Order for Integrated Animal Behavior Monitoring System
April 18, 2023 17:10 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., April 18, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the initial order for the Company’s new high-capacity behavioral...
Harvard Bioscience Schedules First Quarter 2023 Earnings Conference Call for April 25, 2023 at 9:00 AM ET
April 17, 2023 16:45 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., April 17, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for the quarter ended March 31, 2023 before the market opens on April...
Harvard Bioscience to Present at Sidoti Investor Conference March 22-23, 2023
March 16, 2023 17:14 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one...
Harvard Bioscience to Present at KeyBanc Capital Markets Life Sciences & MedTech Investor Forum on March 21, 2023
March 16, 2023 09:25 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., March 16, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) today announced that Chairman and Chief Executive Officer Jim Green will present and host one-on-one...
Harvard Bioscience Announces Fourth Quarter 2022 Financial Results
March 09, 2023 07:00 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., March 09, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the fourth quarter and year ended December 31,...
Harvard Bioscience Schedules Fourth Quarter 2022 Earnings Conference Call for March 9, 2023 at 8:00 AM ET
February 28, 2023 16:10 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Feb. 28, 2023 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) will announce its financial results for fourth quarter ended December 31, 2022 before the market opens on...
Harvard Bioscience Announces CFO Transition
December 12, 2022 08:30 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced the resignation of Michael Rossi, the Company’s chief financial officer...
Harvard Bioscience Announces Third Quarter 2022 Financial Results
November 08, 2022 16:01 ET
|
Harvard Bioscience, Inc.
HOLLISTON, Mass., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Harvard Bioscience, Inc. (Nasdaq: HBIO) (the “Company”) today announced financial results for the third quarter ended September 30, 2022. Jim...